Company Valuation: Core Laboratories Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027
Market Cap 1 1,033 939.9 825.1 812.7 746.4 491.4 -
Change - -8.98% -12.21% -1.51% -8.16% -34.16% -
Enterprise Value (EV) 1,204 1,097 973.2 919.7 746.4 491.4 491.4
Change - -8.87% -11.28% -5.5% -18.84% -34.16% 0%
P/E 53.1x 48.3x 20.5x 26.2x 23.6x 26.1x 13.9x
PBR 6.47x 5.02x - - - - -
PEG - - 0x -1.1x 7.79x -0.7x 0.2x
Capitalization / Revenue 2.2x 1.92x 1.62x 1.55x 1.42x 0.96x 0.91x
EV / Revenue 0x 0x 0x 0x 0x 0.96x 0.91x
EV / EBITDA 0x 0x 0x 0x 0x 8.52x 7.32x
EV / EBIT 0x 0x 0x 0x 0x 11.8x 8.62x
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Dividend per Share 2 0.04 0.04 0.04 0.04 0.04 0.04 0.04
Rate of return 0.18% 0.2% 0.23% 0.23% 0.25% 0.37% 0.37%
EPS 2 0.42 0.42 0.86 0.66 0.68 0.41 0.77
Distribution rate 9.52% 9.52% 4.65% 6.06% 5.88% 9.76% 5.19%
Net sales 1 470.3 489.7 509.8 523.8 526.5 510.8 539.5
EBITDA 1 70.81 61.98 76.96 80.2 73.34 57.67 67.11
EBIT 1 52.29 44.82 61.18 65.25 58.7 41.78 56.98
Net income 1 19.73 19.45 40.94 31.4 31.8 18.92 35.42
Net Debt 170.9 157 148 107 - - -
Reference price 2 22.31 20.27 17.66 17.31 16.03 10.71 10.71
Nbr of stocks (in thousands) 46,290 46,371 46,724 46,950 46,563 45,885 -
Announcement Date 2/2/22 A 2/1/23 A 1/31/24 A 1/29/25 A 2/4/26 A - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
26.12x - - 0.37% 491M
26.11x2.91x13.05x3.28% 23.65B
43.1x5.68x20.93x0.64% 18.35B
20.39x2.92x12.02x1.3% 3.52B
13.19x - - 2.48% 2.21B
-35.64x1.31x8.43x-.--% 1.74B
21.83x - - 2.34% 1.58B
Average 16.44x 3.21x 13.61x 1.49% 7.36B
Weighted average by Cap. 29.00x 3.93x 15.86x 2%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. CLB Stock
  4. Valuation Core Laboratories Inc.